series-a
Stage
2018
Founded
1
Investors
About
GentiBio is a clinical-stage biotechnology company developing engineered regulatory T cell therapies to treat Type 1 diabetes and other autoimmune and acute inflammatory diseases.
Explore GentiBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.